Targeted toxicants to dopaminergic neuronal cell death.

作者: Huajun Jin , Arthi Kanthasamy , Dilshan S. Harischandra , Vellareddy Anantharam , Ajay Rana

DOI: 10.1007/978-1-4939-2152-2_18

关键词:

摘要: Parkinson's disease (PD ) is mainly characterized by a progressive degeneration of dopaminergic neurons in the substantia nigra resulting chronic deficits motor functions. Administration neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP produces PD symptoms and recapitulates main features human animal models. MPTP converted to 1-methyl-4-phenylpyridine (MPP+ ), which active toxic compound that selectively destroys neurons. Here, we describe methods protocols evaluate MPTP/MPP+-induced neurodegeneration both murine primary mesencephalic cultures The ability MPTP/MPP+ cause neuronal cell death assessed immunostaining tyrosine hydroxylase (TH).

参考文章(41)
Fiona Thomson, Parkinson's Disease Neuron. ,vol. 39, pp. 889- 909 ,(2003) , 10.1016/S0896-6273(03)00568-3
JOSEPH JANKOVIC, Parkinson's disease: recent advances in therapy. Southern Medical Journal. ,vol. 81, pp. 1021- ,(1988) , 10.1097/00007611-198808000-00020
George Paxinos, Keith B. J. Franklin, The Mouse Brain in Stereotaxic Coordinates ,(2007)
Serge Przedborski, Vernice Jackson-Lewis, Ali B. Naini, Michael Jakowec, Giselle Petzinger, Reginald Miller, Muhammad Akram, The parkinsonian toxin 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP): a technical review of its utility and safety Journal of Neurochemistry. ,vol. 76, pp. 1265- 1274 ,(2001) , 10.1046/J.1471-4159.2001.00183.X
Ruth Djaldetti, Serge Przedborski, Slobodanka Vukosavic, Gabrielle Almer, Miquel Vila, Vernice Jackson-Lewis, Gabriel Liberatore, The parkinsonian toxin MPTP: action and mechanism. Restorative Neurology and Neuroscience. ,vol. 16, pp. 135- 142 ,(2000)
A. Hartley, J. M. Stone, C. Heron, J. M. Cooper, A. H. V. Schapira, Complex I Inhibitors Induce Dose-Dependent Apoptosis in PC12 Cells: Relevance to Parkinson's Disease Journal of Neurochemistry. ,vol. 63, pp. 1987- 1990 ,(2002) , 10.1046/J.1471-4159.1994.63051987.X
Kim B. Seroogy, Christine M. Gall, Expression of Neurotrophins by Midbrain Dopaminergic Neurons Experimental Neurology. ,vol. 124, pp. 119- 128 ,(1993) , 10.1006/EXNR.1993.1182
Amy B. Manning-BoĞ, J. William Langston, Model fusion, the next phase in developing animal models for Parkinson's disease. Neurotoxicity Research. ,vol. 11, pp. 219- 240 ,(2007) , 10.1007/BF03033569
S.-L. Ang, Transcriptional control of midbrain dopaminergic neuron development. Development. ,vol. 133, pp. 3499- 3506 ,(2006) , 10.1242/DEV.02501
J. Langston, P Ballard, J. Tetrud, I Irwin, Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis Science. ,vol. 219, pp. 979- 980 ,(1983) , 10.1126/SCIENCE.6823561